Effect of intermittent thoracic vertebral block on recovery quality after thoracoscopic surgery

Clinical study of intermittent thoracic paravertebral block in reducing nausea and vomiting after thoracoscopic surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047423

Enrollment

Unknown

Registered

2021-06-18

Start date

2021-06-03

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Experimental group1:Intermittent PVB+PCIA

Experimental group2:SPVB+PCIA

Experimental group3:PCIA

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 75 patients undergoing elective general thoracoscopic surgery; 2. Aged 18 to 65 years; 3. ASA i-ii grade.

Exclusion criteria

Exclusion criteria: 1.Patients are allergic to local anesthetic drugs; 2.Low blood volume, blood disease, or abnormal coagulation function; 3.The puncture area has an infection stove (that is, swelling and hot pain); 4.Weight mass index >= 35kg/m2; 5.Combined with severe hypertension, diabetes, long-term use of cortisol hormones; 6.Unable to understand and use NRS ratings and PCIA.

Design outcomes

Primary

Measure	Time frame
the incidence of postoperative nausea or vomiting;acute postoperative pain;	—

Countries

China

Contacts

Public ContactYu Yulong

Taizhou Hospital of Zhejiang Province

yyl@enzemed.com+86 15867638325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026